tet2 mouse model (New England Biolabs)
Structured Review

Tet2 Mouse Model, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tet2 mouse model/product/New England Biolabs
Average 94 stars, based on 61 article reviews
Images
1) Product Images from "Systematic functional dissection of germline noncoding risk variants impacting clonal hematopoiesis"
Article Title: Systematic functional dissection of germline noncoding risk variants impacting clonal hematopoiesis
Journal: bioRxiv
doi: 10.64898/2026.01.21.700897
Figure Legend Snippet: (A) Schematic of lentiviral MSI2 overexpression constructs and Western blot confirming MSI2 overexpression in K562 cells. (B) Setup of MSI2 overexpression experiments in murine Tet2 -/- hematopoietic stem and progenitor cells (HSPCs). (C) Colony replating assays of sorted GFP + Lin - Sca-1 + c-Kit + (LSK) cells shows increased self-renewal of Tet2 -/- HSPCs upon MSI2 upregulation. (D) Venn diagram showing common and unique differentially expressed genes across different genotypes identified by RNA-Seq (FDR <0.05 and |log2FC| >1.5). “WT MSI2” indicates wild-type HSPCs transduced with MSI2 overexpressing vector; “Tet2 -/- MSI2” indicates Tet2 -/- HSPCs transduced with MSI2 overexpressing vector; “Tet2 -/- HMD” indicates Tet2 -/- HSPCs transduced with empty HMD vector. All groups are compared against WT HSPCs transduced with empty HMD vector, “WT HMD” (n=2 replicates each group). (E) Heatmap showing relative expression of Wnt polarity genes across all groups. (F) Heatmap showing relative expression of Cell cycle genes across groups. (G) Gene set enrichment analysis of MSI2 HyperTRIBE binding targets in Tet2 -/- MSI2 vs. WT HMD. All data are means ± SDs. *p < 0.05, **p < 0.01.
Techniques Used: Over Expression, Construct, Western Blot, RNA Sequencing, Transduction, Plasmid Preparation, Expressing, Binding Assay
Figure Legend Snippet: (A) CFU-C replating assay shows the colonies number from sorted murine GFP+ TET2+/- HSPCs. (B-C) Colony images of 2 nd plating from TET2+/- and TET2-/-HSPCs, respectively. (D) Heatmap showing expression of genes across all genotypes highlighting genes uniquely up- and down-regulated in the KO HMD group (E) Heatmap represents mitochondrial electron transport chain genes expression in different experimental groups. (F) Volcano plots show DEGs expression compared WT MSI2 vs WT HMD, Tet2-/- HMD vs WT HMD, Tet2-/- MSI2 vs Tet2-/- HMD, and Tet2-/- MSI2 vs WT HMD. (G) Gene ontology analysis of downregulated and upregulated pathways between Tet2 -/- MSI2 vs. WT HMD.
Techniques Used: Expressing

![<t>Tet2</t> deficiency impairs memory B‐cell and plasma cell differentiation of IgG1+ germinal center B‐cells . (A) Schematic diagram of the protocol of SRBC primary and secondary immunizations. (B) Representative cytometry plot and quantification of IgM+ and IgG1+ GC B‐cells (CD19+CD95+GL7+) from Tet2 ‐WT and Tet2 ‐KO mice upon primary ( n = 8) and secondary immunization ( n = 18) with SRBC. (C) Representative cytometry plot and quantification of IgM+ and IgG1+ MBCs, (Lin (CD4, CD8, Gr1)‐IgD‐GL7‐CD19+CD38+) from Tet2 ‐WT and Tet2 ‐KO mice upon primary and secondary immunization with SRBC (primary immunization: Tet2 ‐WT [ n = 7] and Tet2 ‐KO [ n = 9]; secondary immunization: Tet2 ‐WT [ n = 9] and Tet2 ‐KO [ n = 10]). (D) Representative cytometry histograms and quantification of the expression of CD80 on the cell surface of IgM+ and IgG1+ MBCs from Tet2 ‐WT ( n = 7) and Tet2 ‐KO ( n = 9) mice upon primary immunization with SRBC. (E) Representative cytometry plot of PBs (CD19+CD138+CD43+) from Tet2 ‐WT ( n = 4) and Tet2 ‐KO ( n = 5) mice upon secondary immunization with SRBC. (F) Representative cytometry plot and quantification of IgM+ and IgG1+ PBs (CD19+CD138+CD43+) from Tet2 ‐WT ( n = 4) and Tet2 ‐KO ( n = 5) mice upon secondary immunization with SRBC. All P values were calculated using an unpaired two‐tailed t ‐test, * P < 0.05, ** P < 0.01, *** P < 0.001 and ns, not significant, in all experiments. GC, germinal center; MBC, memory B cell; PBs, plasmablasts; SRBC, sheep red blood cells.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7087/pmc12797087/pmc12797087__HEM3-10-e70296-g006.jpg)
29 (B) Gene expression levels by RT‐PCR of Nfkbia in Tet2 ‐WT and Tet2 ‐KO GC B‐cells at D8 (IgG1+) and D4 (IgM+ and IgG1+) ( n = 4). (C) Quantification of iPC (GFP+ CD19+ CD138+), iGCB (GFP+ CD19+ CD138− Fas+ GL7+), IgG1+ iGCB (GFP+ CD19+ CD138− Fas+ GL7+ IgG1+), and MFI of IgG1 in IgG1+ iGCB at D11 of the iGCB transduction model, after transduction of Tet2 ‐WT B‐cells by a MSCV containing sh Renilla , a MSCV containing shRNA Nfkbia 1224, or a MSCV containing shRNA Nfkbia 1485 ( n = 4). For A and B, P values were calculated using an unpaired two‐tailed t ‐test. For (C) P values were calculated using a paired RM one‐way ANOVA test, * P < 0.05, ** P < 0.01, *** P < 0.001 and ns, not significant in all experiments. ANOVA, analysis of variance; iGCB, induced germinal center B‐cells; iPC, induced plasma cells; MFI, mean fluorescence intensity; MSCV, murine stem cell virus. " width="100%" height="100%">